Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine as an
adjuvant to ropivacaine: Patients randomized to this
group will receive single shot
costotransverse block with 0.75%
ropivacaine and
dexmedetomidine 1mcg/kg and
wi
Sponsors
Department of Anaesthesia and Intensive care
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists (ASA) class I-II Age more than 18 years at the date of inclusion Females posted for breast surgery Who have received thorough information and have signed the informed written consent form
Exclusion criteria
Exclusion criteria: Patient refusal ASA III- IV including patient with severe respiratory,cardiovascular, liver and metabolic or pre-existing neurological deficit Skin infection at puncture site Allergy to study drugs Recent history of use of analgesic/steroid drugs Pregnant patient History of psychiatric illness and substance abuse. Morbid obesity BMI >40 kg/m2 Coagulation abnormalities (INR >1.5,thrombocytopenia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of dexmedetomidine versus dexamethasone as an adjuvant to ropivacaine on pain relief after costotransverse block by determining the quality of recovery assessed using Quality of Recovery(QoR-15) scale at 24 hour post operatively.Timepoint: At 24 hrs. | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the time for first requirement of analgsia. Total cumulative dose of rescue analgesic (tramadol) consumption in the 24 h after surgery. VAS scores at rest and on arm movements. Patient satisfaction with block. Future willingness to undergo repeat peripheral nerve block. Note any side effects.Timepoint: 1hr, 4hr, 8hr, 12hr, 24hr. | — |
Countries
India
Contacts
Public ContactDr Swati
Government Medical College and Hospital, Sector 32 Chandigarh.
Outcome results
None listed